Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Vivian Shi

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentDermatology, College of Medicine
DivisionDermatology Faculty
Address4301 W. Markham
Mail Slot # 5765
Little Rock AR 72205
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    ASLAN004     (SHI, VIVIAN Y)May 16, 2022 - May 15, 2032
    ASLAN Pharmaceuticals Pte. Ltd. - Pass Through: IQVIA, Inc.
    A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Trial to Evaluate the Efficacy and Safety of ASLAN004 in Adult Patients with Moderate-to-Severe Atopic Dermatitis (IRB 273816)
    Role: Principal Investigator
    ASLAN004-003     (SHI, VIVIAN Y)May 16, 2022 - May 15, 2032
    ASLAN Pharmaceuticals Pte. Ltd. - Pass Through: IQVIA, Inc.
    A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Trial to Evaluate the Efficacy and Safety of ASLAN004 in Adult Patients with Moderate-to-Severe Atopic Dermatitis (IRB 273816)
    Role: Principal Investigator
    NIS-TRALO     (SHI, VIVIAN Y)May 10, 2022 - May 9, 2032
    LEO Pharma A/S - Pass Through: Outcome Sciences, Inc.
    Tralokinumab ReAl world Clinical usE: An observational cohort study of atopic dermatitis patients prescribed Tralokinumab (IRB 273919)
    Role: Principal Investigator
    NIS-TRALO-2213     (SHI, VIVIAN Y)May 10, 2022 - May 9, 2032
    LEO Pharma A/S - Pass Through: Outcome Sciences, Inc.
    Tralokinumab ReAl world Clinical usE: An observational cohort study of atopic dermatitis patients prescribed Tralokinumab (IRB 273919)
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Masson R, Park SE, Shih T, Hogeling M, Shi VY, Hsiao JL. Spironolactone in hidradenitis suppurativa: a single-center. Int J Womens Dermatol. 2024 Mar; 10(1):e135. PMID: 38505270.
      View in: PubMed
    2. Park SE, Shih T, Dagenet C, Hogeling M, Hughes M, Gillenwater J, Shi VY, Hsiao JL. Pediatric hidradenitis suppurativa publication trends: 2012 to 2022. Pediatr Dermatol. 2024 Feb 26. PMID: 38409741.
      View in: PubMed
    3. Aldredge LM, Chamberlain WD, Shi VY. Podcast on Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases. Dermatol Ther (Heidelb). 2024 Feb; 14(2):293-302. PMID: 38308800.
      View in: PubMed
    4. Stein Gold LF, Tom WL, Shi V, Sanders P, Zang C, Vlahos B, Cha A. Impact of Crisaborole in Treatment-Experienced Patients With Mild-to-Moderate Atopic Dermatitis. Dermatitis. 2024 Jan-Feb; 35(1):84-91. PMID: 38206678.
      View in: PubMed
    5. Park SE, Masson R, Shih T, Shi VY, Hsiao JL, Aleshin MA. Patient practices in hidradenitis suppurativa flare management: a cross-sectional survey study. Arch Dermatol Res. 2023 Dec 04; 316(1):13. PMID: 38047926.
      View in: PubMed
    6. Masson R, Ma E, Park S, Dagenet CB, Crew AB, Hughes M, Shi VY, Hsiao JL. Top cited articles in dissecting cellulitis of the scalp: A bibliometric analysis. Skin Res Technol. 2023 Nov; 29(11):e13509. PMID: 38009045.
      View in: PubMed
    7. Atluri S, Jeong C, Rick JW, Dagenet C, Tran KA, De DR, Masson R, Hsiao JL, Shi VY. Allergens and Marketing Claims of Popular Baby Washes. Dermatitis. 2023 Oct 27. PMID: 37890118.
      View in: PubMed
    8. Masson R, Jeong CY, Ma E, Crew AB, Fragoso NM, Shi VY, Hsiao JL. Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2487-2526. PMID: 37740150.
      View in: PubMed
    9. Rajkumar J, Chandan N, Lio P, Shi V. The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair. Skin Pharmacol Physiol. 2023; 36(4):174-185. PMID: 37717558.
      View in: PubMed
    10. Atluri S, Masson R, Tran K, Hsiao JL, Shi VY. Managing seasonal flares in hidradenitis suppurativa. J Am Acad Dermatol. 2024 Jan; 90(1):e23-e24. PMID: 37716369.
      View in: PubMed
    11. Atluri S, De DR, Shih T, Masson R, Tran KA, Partha I, Hsiao JL, Shi VY. Perspectives and experiences of primary care providers on hidradenitis suppurativa care. Int J Dermatol. 2024 Feb; 63(2):e60-e62. PMID: 37691008.
      View in: PubMed
    12. Masson R, Ma E, Parvathala N, Shih T, Atluri S, Hogeling M, Hughes M, Sayed CJ, Shi VY, Hsiao JL. Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review. Pediatr Dermatol. 2023 Sep-Oct; 40(5):775-788. PMID: 37525978.
      View in: PubMed
    13. Masson R, Shih T, Jeong C, Shi VY, Hsiao JL. Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review. J Drugs Dermatol. 2023 Aug 01; 22(8):785-794. PMID: 37556513.
      View in: PubMed
    14. Silverberg JI, Shi VY, Alexis A, Pierce E, Cronin A, McLean RR, Roberts-Toler C, Rueda MJ, Atwater AR, Simpson E. Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry. Dermatol Ther (Heidelb). 2023 Sep; 13(9):2045-2061. PMID: 37481484.
      View in: PubMed
    15. Fragoso NM, Masson R, Gillenwater TJ, Shi VY, Hsiao JL. Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa-Part II: Procedural and Wound Care Therapies. Dermatol Ther (Heidelb). 2023 Aug; 13(8):1699-1720. PMID: 37402030.
      View in: PubMed
    16. Fragoso NM, Masson R, Gillenwater TJ, Shi VY, Hsiao JL. Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. Dermatol Ther (Heidelb). 2023 Aug; 13(8):1661-1697. PMID: 37402031.
      View in: PubMed
    17. Tinguely Y, Shi V, Klatte-Schulz F, Duda GN, Freedman BR, Mooney DJ. Aging and injury affect nuclear shape heterogeneity in tendon. J Orthop Res. 2023 10; 41(10):2186-2194. PMID: 37316467.
      View in: PubMed
    18. Masson R, Shih T, Park S, De DR, Gierbolini A, Alavi A, Garg A, Micheletti RG, Shi VY, Hsiao JL. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study. Dermatology. 2023; 239(5):732-737. PMID: 37385230.
      View in: PubMed
    19. Shi V, Stein Q, Clark D, Punj S, Kremsdorf R, Faizan M. Isolated benign persistent proteinuria with novel association of CUBN (cubilin) variants. Clin Case Rep. 2023 Jun; 11(6):e7502. PMID: 37312928.
      View in: PubMed
    20. Masson R, Seivright J, Shih T, Bennett RG, Hogeling M, Shi VY, Hsiao JL. Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases. JAAD Case Rep. 2023 Jul; 37:1-4. PMID: 37332359.
      View in: PubMed
    21. Masson R, Parvathala N, Ma E, Shih T, Atluri S, Sayed CJ, Hogeling M, Shi VY, Hsiao JL. Efficacy of procedural treatments for pediatric hidradenitis suppurativa: A systematic review. Pediatr Dermatol. 2023 Jul-Aug; 40(4):595-605. PMID: 37092729.
      View in: PubMed
    22. Yamanaka-Takaichi M, Revankar R, Shih T, Gall M, Hsiao JL, Shi VY, Alavi A. Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study. Arch Dermatol Res. 2023 Sep; 315(7):2129-2136. PMID: 36951970.
      View in: PubMed
    23. De DR, Rick JW, Shih T, Hsiao JL, Hamzavi I, Shi VY. COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study. Skin Appendage Disord. 2023 Jun; 9(3):203-206. PMID: 37325275.
      View in: PubMed
    24. Shih T, Lee K, Aleshin M, Bennett R, Mayo T, Okoye GA, Villa N, Sayed CJ, Shi VY, Hsiao JL. A practical guide to starting a hidradenitis suppurativa specialty clinic. JAAD Int. 2023 Jun; 11:117-120. PMID: 36950265.
      View in: PubMed
    25. Shi VY, Chamberlain W, Siegfried E, Kraff-Cooper C, Beckman K, Lio P, Paller AS, Simpson E. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review. J Am Acad Dermatol. 2023 08; 89(2):309-315. PMID: 36806642.
      View in: PubMed
    26. Lio P, Mackie D, Bates D, Mulvihill E, Patel M, Kim Y, Shi V. Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study. J Drugs Dermatol. 2023 Feb 01; 22(2):119-131. PMID: 36745377.
      View in: PubMed
    27. Shih T, De DR, Rick J, Shi VY, Hsiao JL. Low Rates of Psychosocial Screening and Lifestyle Counseling in Hidradenitis Suppurativa Patients in the USA. Skin Appendage Disord. 2023 Mar; 9(2):94-98. PMID: 36937161.
      View in: PubMed
    28. Rick JW, Lio P, Atluri S, Hsiao JL, Shi VY. Atopic Dermatitis: A Guide to Transitioning to Janus Kinase Inhibitors. Dermatitis. 2023 Jul-Aug; 34(4):297-300. PMID: 36125529.
      View in: PubMed
    29. Garg A, Naik HB, Alavi A, Hazen P, Hsiao JL, Shi VY, Weisman J, Tran T, Rudnik J, Jedrzejczyk A, Pansar I, Kimball AB. Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data. Dermatol Ther (Heidelb). 2023 Feb; 13(2):581-594. PMID: 36585607.
      View in: PubMed
    30. Shih T, Zell M, Karlin D, De DR, Smogorzewski J, Shi VY, Hsiao JL. Integrating primary palliative care into hidradenitis suppurativa management. Int J Womens Dermatol. 2022 Dec; 8(4):e063. PMID: 36567965.
      View in: PubMed
    31. Masson R, Shih T, De DR, Park S, Parvataneni R, Goldberg A, Sayed CJ, Shi VY, Hsiao JL. Perspectives of obstetricians/gynecologists on hidradenitis suppurativa care: a survey study. Int J Womens Dermatol. 2022 Dec; 8(4):e064. PMID: 36419800.
      View in: PubMed
    32. Hsiao JL, Shi VY, Muscianisi E, Nguyen E, Darcy J, Kirby JS. Patient perspectives on diagnosis and management of hidradenitis suppurativa: A web-based survey. JAAD Int. 2022 Dec; 9:139-141. PMID: 36311912.
      View in: PubMed
    33. Shi VY, Hsiao JL, Muscianisi E, Nguyen E, Darcy J, Kirby JS. A survey of dermatologist perspectives on disease management of patients with hidradenitis suppurativa. JAAD Int. 2022 Dec; 9:94-96. PMID: 36237848.
      View in: PubMed
    34. Shih T, De DR, Tran KA, Hsiao JL, Shi VY. Health Literacy in Dermatology Patients: How to Level the Playing Field. Cutis. 2022 Sep; 110(3):119-120. PMID: 36446108.
      View in: PubMed
    35. Shih T, De DR, Brooks B, Fixsen D, Shi VY, Hsiao JL. Optimizing hidradenitis suppurativa clinic visits: Patient perspectives. Int J Womens Dermatol. 2022 Oct; 8(3):e040. PMID: 36000014.
      View in: PubMed
    36. Rick JW, Brannon M, De DR, Shih T, Hsiao JL, Shi VY. Allergen Composition, Marketing Claims, and Affordability of Pediatric Sunscreens. Dermatitis. 2022 Nov-Dec 01; 33(6):435-441. PMID: 35951431.
      View in: PubMed
    37. Shih T, De DR, Fixsen D, Brooks B, Shi VY, Hsiao JL. Hidradenitis suppurativa surgery: patient perspectives and barriers. Int J Dermatol. 2023 04; 62(4):e270-e272. PMID: 35933652.
      View in: PubMed
    38. Shih T, De D, Daveluy SD, Hogeling M, Lowes MA, Sayed C, Shi VY, Hsiao JL. Real-World Considerations of Candidacy for Biologics in Hidradenitis Suppurativa. Am J Clin Dermatol. 2022 Nov; 23(6):749-753. PMID: 35930133.
      View in: PubMed
    39. Shih T, Lee K, Grogan T, De DR, Shi VY, Hsiao JL. Infliximab in hidradenitis suppurativa: A systematic review and meta-analysis. Dermatol Ther. 2022 09; 35(9):e15691. PMID: 35790062.
      View in: PubMed
    40. De DR, Shih T, Fixsen D, Brooks B, Hsiao JL, Shi VY. Biologic use in hidradenitis suppurativa: patient perspectives and barriers. J Dermatolog Treat. 2022 Nov; 33(7):3060-3062. PMID: 35737883.
      View in: PubMed
    41. Shi VY, Burney W, Shakhbazova A, Pan A, Hassoun LA, Sharma S, Sivamani RK. The effect of synthetic acetylhexapeptide-8 (AH8) on sebaceous function. Int J Cosmet Sci. 2022 Aug; 44(4):477-483. PMID: 35690997.
      View in: PubMed
    42. Thompson AM, Rick JW, De DR, Fernandez JM, Maarouf M, Seivright JR, Hsiao JL, Shi VY. Relationship Disturbances in Hidradenitis Suppurativa: A Patient Perspective. Skin Appendage Disord. 2022 Nov; 8(6):448-453. PMID: 36407648.
      View in: PubMed
    43. Thompson AM, Seivright J, Hsiao JL, Shi VY. Bibliometric analysis of the 50 most cited publications in atopic dermatitis. Pediatr Dermatol. 2022 Jul; 39(4):578-583. PMID: 35510832.
      View in: PubMed
    44. De DR, Shih T, Hsiao JL, Shi VY. Readability, Quality, and Comprehensiveness of Patient Online Health Resources for Hand Dermatitis. Dermatitis. 2022 May-Jun 01; 33(3):e31-e33. PMID: 35594459.
      View in: PubMed
    45. Rick JW, Morgan A, De DR, Hsiao JL, Shi VY. Allergens and marketing claims of the most popular baby moisturizers: A product analysis. J Am Acad Dermatol. 2023 01; 88(1):205-207. PMID: 35487334.
      View in: PubMed
    46. Hwang J, Rick J, Hsiao J, Shi VY. A review of IL-36: an emerging therapeutic target for inflammatory dermatoses. J Dermatolog Treat. 2022 Sep; 33(6):2711-2722. PMID: 35470744.
      View in: PubMed
    47. Worm M, Thyssen JP, Schliemann S, Bauer A, Shi VY, Ehst B, Tillmann S, Korn S, Resen K, Agner T. The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial. Br J Dermatol. 2022 07; 187(1):42-51. PMID: 35084738.
      View in: PubMed
    48. Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022 08; 87(2):351-358. PMID: 35439608.
      View in: PubMed
    49. Seivright J, Collier E, Grogan T, Shih T, Hogeling M, Shi VY, Hsiao JL. Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments. J Dermatolog Treat. 2022 06; 33(4):2391-2393. PMID: 34057384.
      View in: PubMed
    50. Shih T, Seivright J, Thompson AM, Atluri S, Shi VY, Hsiao JL. Hidradenitis suppurativa publication trends from Latin America from 2009 to 2019: A bibliometric analysis. Int J Womens Dermatol. 2022 Mar; 8(1):e007. PMID: 35620024.
      View in: PubMed
    51. Rick JW, Lio P, Hsiao JL, Shi VY. Response to: "Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication". J Am Acad Dermatol. 2022 07; 87(1):e33-e34. PMID: 35307489.
      View in: PubMed
    52. Collier EK, Sachdeva M, Yazdani S, Hogeling M, Okun M, Naik HB, Lowes MA, Hsiao JL, Shi VY. Diagnosing and Managing Hidradenitis Suppurativa in Pediatrics. Pediatr Ann. 2022 Mar; 51(3):e123-e127. PMID: 35293815.
      View in: PubMed
    53. Hwang J, Newton EM, Hsiao J, Shi VY. Aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis. Exp Dermatol. 2022 04; 31(4):485-497. PMID: 35174548.
      View in: PubMed
    54. De DR, Shih T, Katta R, Hsiao JL, Shi VY. Readability, Quality, and Timeliness of Patient Online Health Resources for Contact Dermatitis and Patch Testing. Dermatitis. 2022 Mar-Apr 01; 33(2):155-160. PMID: 34570732.
      View in: PubMed
    55. Rick JW, De DR, Shih T, Alavi A, Kirby JS, Naik HB, Frew JW, Sayed CJ, Hsiao JL, Shi VY. Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts. Skin Appendage Disord. 2022 Jul; 8(4):287-290. PMID: 35979524.
      View in: PubMed
    56. Seivright JR, Villa NM, De DR, Hsiao JL, Shi VY. Intralesional biologics for inflammatory dermatoses: A systematic review. Dermatol Ther. 2022 02; 35(2):e15234. PMID: 34825744.
      View in: PubMed
    57. Shih T, Lee K, Seivright JR, De DR, Shi VY, Hsiao JL. Hyperhidrosis treatments in hidradenitis suppurativa: A systematic review. Dermatol Ther. 2022 01; 35(1):e15210. PMID: 34796606.
      View in: PubMed
    58. Harpaldas H, Arumugam S, Campillo Rodriguez C, Kumar BA, Shi V, Sia SK. Point-of-care diagnostics: recent developments in a pandemic age. Lab Chip. 2021 11 25; 21(23):4517-4548. PMID: 34778896.
      View in: PubMed
    59. Shih T, De DR, Thompson AM, Seivright JR, Atluri S, Ederle A, Swigert A, Jaros JA, Hsiao JL, Shi VY. Global geographic bibliometric analysis of hidradenitis suppurativa publications. Int J Dermatol. 2022 11; 61(11):e453-e455. PMID: 34658018.
      View in: PubMed
    60. Shih T, Shi V, Hsiao JL. Treatment Stacking: Optimizing Therapeutic Regimens for Hidradenitis Suppurativa. Cutis. 2021 Oct; 108(4):176-178. PMID: 34846994.
      View in: PubMed
    61. Hassoun LA, Shi VY, Sivamani RK. Phototoxicity Secondary to Home Fireplace Exposure After Photodynamic Therapy for Actinic Keratosis. Cutis. 2021 Oct; 108(4):E29-E31. PMID: 34847013.
      View in: PubMed
    62. Thompson AM, Hsiao JL, Shi VY. National Institutes of Health Funding Trends for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e94-e96. PMID: 34405838.
      View in: PubMed
    63. Carnicle JM, Hendricks AJ, Shi VY. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e80-e82. PMID: 31441782.
      View in: PubMed
    64. Modiri O, Yee D, Shi VY, Hsiao JL. Readability, Quality, and Timeliness of Online Health Resources for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e89-e91. PMID: 33273239.
      View in: PubMed
    65. Ludwig CM, Hsiao JL, Lio PA, Shi VY. Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):S4-S7. PMID: 33273236.
      View in: PubMed
    66. Thompson AM, Fernandez JM, Shih T, Hamzavi I, Hsiao JL, Shi VY. Improving hidradenitis suppurativa patient education using written action plan: a randomized controlled trial. J Dermatolog Treat. 2022 Aug; 33(5):2677-2679. PMID: 34579620.
      View in: PubMed
    67. Seivright JR, Collier E, Grogan T, Shih T, Hogeling M, Shi VY, Hsiao JL. Management Landscape of Pediatric Hidradenitis Suppurativa. Skin Appendage Disord. 2022 Mar; 8(2):118-121. PMID: 35419424.
      View in: PubMed
    68. Thompson AM, Atluri S, Hsiao JL, Shi VY. Editorial board members of the top four dermatology journals. Int J Dermatol. 2022 11; 61(11):e434-e436. PMID: 34530486.
      View in: PubMed
    69. Seivright JR, Collier E, Grogan T, Hogeling M, Shi VY, Hsiao JL. Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: A retrospective analysis. Pediatr Dermatol. 2021 Sep; 38(5):1132-1136. PMID: 34463372.
      View in: PubMed
    70. Seivright JR, Villa NM, Grogan T, Parvataneni RK, Thompson AM, Shi VY, Hsiao JL. Impact of Pregnancy on Hidradenitis Suppurativa Disease Course: A Systematic Review and Meta-Analysis. Dermatology. 2022; 238(2):260-266. PMID: 34515085.
      View in: PubMed
    71. De DR, Thompson AM, Seivright J, Atluri S, Ederle A, Swigert A, Jaros J, Hsiao JL, Shi VY. Bibliometric Analysis of Hidradenitis Suppurativa Publication Trends from Asia and Australasia. Skin Appendage Disord. 2022 Jan; 8(1):20-23. PMID: 35118124.
      View in: PubMed
    72. Thompson AM, Atluri S, Yee D, Price KN, Hsiao JL, Shi VY. Academic dermatology chair and chief characteristics. Int J Womens Dermatol. 2021 Dec; 7(5Part B):860-862. PMID: 35028403.
      View in: PubMed
    73. Hwang J, Thompson A, Jaros J, Blackcloud P, Hsiao J, Shi VY. Updated understanding of Staphylococcus aureus in atopic dermatitis: From virulence factors to commensals and clonal complexes. Exp Dermatol. 2021 10; 30(10):1532-1545. PMID: 34293242.
      View in: PubMed
    74. Rick JW, Thompson AM, Fernandez JM, Maarouf M, Seivright JR, Hsiao JL, Shi VY. Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey. Australas J Dermatol. 2021 Nov; 62(4):e592-e594. PMID: 34314017.
      View in: PubMed
    75. Shih T, Seivright JR, McKenzie SA, Harview CL, Truong AK, Shi VY, Bennett RG, Hsiao JL. Gender differences in hidradenitis suppurativa characteristics: A retrospective cohort analysis. Int J Womens Dermatol. 2021 Dec; 7(5Part B):672-674. PMID: 35028362.
      View in: PubMed
    76. Rick JW, Alavi A, Hsiao JL, Yosipovitch G, Shi VY. Atopic dermatitis and hidradenitis suppurativa: An under-recognized pair. J Am Acad Dermatol. 2021 12; 85(6):e387-e388. PMID: 34214619.
      View in: PubMed
    77. Villa NM, Shih T, Rick JW, Shi VY, Hsiao JL. Pyoderma gangrenosum: Readability and quality of online health resources. Int J Womens Dermatol. 2021 Dec; 7(5Part B):850-852. PMID: 35028400.
      View in: PubMed
    78. de Almeida M, Zheng Y, Nascimento FS, Bishop H, Cama VA, Batra D, Unoarumhi Y, Afghan AK, Shi VY, LeBoit PE, Liu EW, Donovan FM. Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA. Emerg Infect Dis. 2021 06; 27(6):1714-1717. PMID: 34013870.
      View in: PubMed
    79. Seivright JR, Thompson A, Hamzavi I, Lowes MA, Porter M, Shi VY, Hsiao JL. Hidradenitis Suppurativa Specialty Clinics in the USA. Skin Appendage Disord. 2021 Aug; 7(5):359-362. PMID: 34604323.
      View in: PubMed
    80. Chandan N, Rajkumar JR, Shi VY, Lio PA. A new era of moisturizers. J Cosmet Dermatol. 2021 Aug; 20(8):2425-2430. PMID: 33977643.
      View in: PubMed
    81. De DR, Seivright J, Yee D, Hsiao JL, Shi VY. Readability, quality, and timeliness of patient online health resources for urticaria. J Am Acad Dermatol. 2022 05; 86(5):1182-1185. PMID: 33951494.
      View in: PubMed
    82. Seivright J, Thompson AM, Atluri S, Ederle A, Swigert A, Jaros J, Shi VY, Hsiao JL. Hidradenitis suppurativa research from Africa: a bibliometric analysis. Int J Dermatol. 2021 Oct; 60(10):e410-e414. PMID: 33844314.
      View in: PubMed
    83. Villa NM, Shi VY, Hsiao JL. An underrecognized barrier to the dermatology residency match: Lack of a home program. Int J Womens Dermatol. 2021 Sep; 7(4):512-513. PMID: 34621973.
      View in: PubMed
    84. Price KN, Collier EK, Grogan T, Fernandez JM, Alhusayen R, Alavi A, Hamzavi IH, Lowes MA, Porter MJ, Hsiao JL, Shi VY. Physician perspectives on complementary and alternative medicine in hidradenitis suppurativa. Dermatol Ther. 2021 03; 34(2):e14851. PMID: 33547869.
      View in: PubMed
    85. Villa NM, Seivright JR, Worswick SD, Shi VY, Hsiao JL. Pityriasis rubra pilaris: a bibliometric analysis. Int J Dermatol. 2021 Aug; 60(8):e326-e331. PMID: 33611794.
      View in: PubMed
    86. Thompson AM, Atluri S, Price KN, Hsiao JL, Shi VY. Medicaid and Medicare Part B spending on immunomodulators and biosimilars. J Dermatolog Treat. 2022 May; 33(3):1762-1764. PMID: 33577369.
      View in: PubMed
    87. Seivright JR, Thompson AM, Villa NM, Shi VY, Hsiao JL. Bibliometric Analysis of the 50 Most Cited Publications in Hidradenitis Suppurativa. Skin Appendage Disord. 2021 Apr; 7(3):173-179. PMID: 34055904.
      View in: PubMed
    88. Price KN, Collier EK, Grogan TR, Hsiao JL, Shi VY. Hidradenitis suppurativa patient perspectives during the COVID-19 pandemic. Dermatol Online J. 2021 Feb 15; 27(2). PMID: 33818992.
      View in: PubMed
    89. Rick J, Thompson AM, Hsiao JL, Liao W, Shi VY. Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns. J Dermatolog Treat. 2022 05; 33(3):1794-1797. PMID: 33494626.
      View in: PubMed
    90. Thompson AM, Price KN, Atluri S, Yee D, Hsiao JL, Shi VY. Gender gaps in National Institutes of Health dermatology grant recipients. Int J Womens Dermatol. 2021 Sep; 7(4):441-444. PMID: 34632037.
      View in: PubMed
    91. Thompson AM, Seivright J, Atluri S, Ederle A, Jaros J, Hsiao JL, Shi VY. Radiotherapy for Hidradenitis Suppurativa: A Systematic Review. Dermatology. 2021; 237(3):357-364. PMID: 33535201.
      View in: PubMed
    92. Thompson AM, Yu L, Hsiao JL, Shi VY. Dermatology-ophthalmology collaborations are needed in dupilumab-associated ocular events. J Am Acad Dermatol. 2021 06; 84(6):e279-e280. PMID: 33476727.
      View in: PubMed
    93. Seivright JR, Cheng MY, Villa NM, Shi VY, Hsiao JL. Bibliometric analysis of original research in four high-impact dermatology journals. Int J Dermatol. 2021 Aug; 60(8):e320-e323. PMID: 33452677.
      View in: PubMed
    94. Ludwig CM, Krase JM, Shi VY. T Helper 2 Inhibitors in Allergic Contact Dermatitis. Dermatitis. 2021 Jan-Feb 01; 32(1):15-18. PMID: 32496280.
      View in: PubMed
    95. Fernandez JM, Rizvi OH, Marr KD, Hendricks AJ, Maarouf M, Price KN, Ludwig CM, Hsiao JL, Shi VY. Topography of lesion progression in hidradenitis suppurativa. Int J Dermatol. 2021 Aug; 60(8):e323-e325. PMID: 33369730.
      View in: PubMed
    96. Collier EK, Seivright JR, Shi VY, Hsiao JL. Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety. Dermatol Ther. 2021 01; 34(1):e14674. PMID: 33320387.
      View in: PubMed
    97. Sachdeva M, Thompson AM, Hsiao JL, Shi VY. Reply to commentary to: Gender and rank salary trends among academic dermatologists. Int J Womens Dermatol. 2021 Mar; 7(2):231. PMID: 33937499.
      View in: PubMed
    98. Price KN, Lyons AB, Hamzavi IH, Hsiao JL, Shi VY. Facilitating Clinical Trials Participation of Low Socioeconomic Status Patients. Dermatology. 2021; 237(5):843-846. PMID: 33321504.
      View in: PubMed
    99. Collier EK, Price KN, Grogan T, Fernandez JM, Seivright JR, Alhusayen R, Alavi A, Hamzavi IH, Lowes MA, Porter MJ, Shi VY, Hsiao JL. Provider perspectives on the management of hidradenitis suppurativa in pregnancy - A survey study. Int J Womens Dermatol. 2021 Jun; 7(3):346-348. PMID: 34222596.
      View in: PubMed
    100. Price KN, Hendricks AJ, Goodrich ME, Krase JM, Shi VY. Widespread pustular eruption following probiotic use. Dermatol Online J. 2020 Nov 15; 26(11). PMID: 33342179.
      View in: PubMed
    101. Berman HS, Shi VY, Hsiao JL. Challenges of Teledermatology: Lessons Learned During COVID-19 Pandemic. Dermatol Online J. 2020 Nov 15; 26(11). PMID: 33342172.
      View in: PubMed
    102. Shi V, Hsiao JL, Shi VY. COVID-19 skin manifestations: the new great imitator? Dermatol Online J. 2020 Nov 15; 26(11). PMID: 33342186.
      View in: PubMed
    103. Yee D, Collier EK, Atluri S, Jaros J, Shi VY, Hsiao JL. Gender differences in sexual health impairment in hidradenitis suppurativa: A systematic review. Int J Womens Dermatol. 2021 Jun; 7(3):259-264. PMID: 34222580.
      View in: PubMed
    104. Atluri S, Seivright JR, Shi VY, Hsiao JL. Volunteer and work experiences among dermatology residency applicants. J Am Acad Dermatol. 2021 02; 84(2):e97-e98. PMID: 33007333.
      View in: PubMed
    105. Collier EK, Parvataneni RK, Lowes MA, Naik HB, Okun M, Shi VY, Hsiao JL. Diagnosis and management of hidradenitis suppurativa in women. Am J Obstet Gynecol. 2021 01; 224(1):54-61. PMID: 32980357.
      View in: PubMed
    106. Fernandez JM, Thompson AM, Borgstrom M, Orenstein LAV, Hsiao JL, Shi VY. Pain management modalities for hidradenitis suppurativa: a patient survey. J Dermatolog Treat. 2022 May; 33(3):1742-1745. PMID: 32914659.
      View in: PubMed
    107. McKenzie SA, Harview CL, Truong AK, Grogan TR, Shi VY, Bennett RG, Hsiao JL. Physical symptoms and psychosocial problems associated with hidradenitis suppurativa: correlation with Hurley stage. Dermatol Online J. 2020 Sep 15; 26(9). PMID: 33054933.
      View in: PubMed
    108. Collier EK, Price KN, Grogan TR, Naik HB, Shi VY, Hsiao JL. Characterizing perimenstrual flares of hidradenitis suppurativa. Int J Womens Dermatol. 2020 Dec; 6(5):372-376. PMID: 33898701.
      View in: PubMed
    109. Thompson AM, Chan A, Torabi M, Kromenacker B, Price KN, Hsiao JL, Shi VY. Eczema moisturizers: Allergenic potential, marketing claims, and costs. Dermatol Ther. 2020 11; 33(6):e14228. PMID: 32844562.
      View in: PubMed
    110. Fernandez JM, Marr KD, Hendricks AJ, Price KN, Ludwig CM, Maarouf M, Hsiao JL, Shi VY. Alleviating and exacerbating foods in hidradenitis suppurativa. Dermatol Ther. 2020 11; 33(6):e14246. PMID: 32860476.
      View in: PubMed
    111. Ludwig CM, Fernandez JM, Hsiao JL, Shi VY. The Interplay of Atopic Dermatitis and Sexual Health. Dermatitis. 2020 Sep/Oct; 31(5):303-308. PMID: 32496279.
      View in: PubMed
    112. Sachdeva M, Price KN, Hsiao JL, Shi VY. Pearls for Managing Atopic Dermatitis in Patients With Low Socioeconomic Status. Dermatitis. 2020 Sep/Oct; 31(5):297-302. PMID: 32947458.
      View in: PubMed
    113. Berman HS, Thomas L, Beynet D, Gates G, Shi V, Hsiao J. Fish tank granuloma during tumor necrosis factor-alpha inhibitor treatment: A case report and literature review. Dermatol Ther. 2020 11; 33(6):e14058. PMID: 32705736.
      View in: PubMed
    114. Yee D, Modiri O, Shi VY, Hsiao JL. Readability, quality, and timeliness of online health resources for rosacea. Int J Dermatol. 2021 Mar; 60(3):e90-e92. PMID: 32857386.
      View in: PubMed
    115. Ludwig CM, Haleen H, Hsiao JL, Lio PA, Shi VY. Emerging rheumatologic reactions with Th2 blockade. Dermatol Ther. 2020 11; 33(6):e14069. PMID: 32710486.
      View in: PubMed
    116. McKenzie SA, Vandiver AR, Villa NM, Smart CN, Shi VY, Hsiao JL. Recalcitrant facial rash: Cutaneous coccidioidomycosis. Int J Womens Dermatol. 2020 Dec; 6(5):458-459. PMID: 33898722.
      View in: PubMed
    117. Jaros J, Wilson C, Shi VY. Fabric Selection in Atopic Dermatitis: An Evidence-Based Review. Am J Clin Dermatol. 2020 Aug; 21(4):467-482. PMID: 32440827.
      View in: PubMed
    118. Hendricks AJ, Maarouf M, Mills BW, Bertoch ST, Davis TL, Shi VY. Erythrodermic Darier disease associated with metastatic lung adenocarcinoma. Dermatol Online J. 2020 Jul 15; 26(7). PMID: 32898399.
      View in: PubMed
    119. Thompson AM, Kromenacker B, Loh TY, Ludwig CM, Segal R, Shi VY. Allergenic potential, marketing claims, and pricing of facial moisturizers. Dermatol Online J. 2020 Jul 15; 26(7). PMID: 32898414.
      View in: PubMed
    120. Fernandez JM, Rizvi OH, Marr KD, Price KN, Hendricks AJ, Hsiao JL, Shi VY. Itch and pain by lesion morphology in hidradenitis suppurativa patients. Int J Dermatol. 2021 Feb; 60(2):e56-e59. PMID: 32662883.
      View in: PubMed
    121. Madsen S, Price KN, Shi VY, Lio PA. Pearls in Mitigating Application Pain of Topical Nonsteroidal Agents. Dermatology. 2020; 236(5):477-480. PMID: 32659770.
      View in: PubMed
    122. Fernandez JM, Hendricks AJ, Thompson AM, Mata EM, Collier EK, Grogan TR, Shi VY, Hsiao JL. Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey. Int J Womens Dermatol. 2020 Dec; 6(5):368-371. PMID: 33898700.
      View in: PubMed
    123. Hwang J, Jaros J, Shi VY. Staphylococcus aureus in Atopic Dermatitis: Past, Present, and Future. Dermatitis. 2020 Jul/Aug; 31(4):247-258. PMID: 32209864.
      View in: PubMed
    124. Kang NC, Hsiao J, Shi V, Naik HB, Lowes MA, Alavi A. Remote management of hidradenitis suppurativa in a pandemic era of COVID-19. Int J Dermatol. 2020 Sep; 59(9):e318-e320. PMID: 32578210.
      View in: PubMed
    125. Price KN, Alavi A, Hsiao JL, Shi VY. Gender minority patients in dermatology clinical trials. Int J Womens Dermatol. 2020 Dec; 6(5):438-439. PMID: 33898715.
      View in: PubMed
    126. Narla S, Price KN, Sachdeva M, Shah M, Shi V, Hamzavi I, Alavi A, Lowes MA. Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019. J Am Acad Dermatol. 2021 Jan; 84(1):120-129. PMID: 32497690.
      View in: PubMed
    127. Lyons AB, Peacock A, McKenzie SA, Jacobsen G, Naik HB, Shi VY, Hamzavi IH, Hsiao JL. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum. JAMA Dermatol. 2020 06 01; 156(6):681-685. PMID: 32347884.
      View in: PubMed
    128. Uthoff R, Song B, Maarouf M, Shi V, Liang R. Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring. J Biomed Opt. 2020 06; 25(6):1-21. PMID: 32578406.
      View in: PubMed
    129. Price KN, Collier EK, Atluri S, Hsiao JL, Shi VY. National Institutes of Health Dermatology Funding Trends 2015-2019. J Invest Dermatol. 2021 01; 141(1):232-235. PMID: 32464149.
      View in: PubMed
    130. Kamil MAA, Chandran NS, Sulistyaningrum SK, Rajagopalan M, Tahiliani S, Hsiao J, Naik H, Shi V, Frew JW. The?Asia Pacific Hidradenitis Suppurativa (APHiS) foundation: promoting hidradenitis suppurativa research in the Asia Pacific. Int J Dermatol. 2020 Aug; 59(8):e289-e290. PMID: 32436230.
      View in: PubMed
    131. Price KN, Atluri S, Hsiao JL, Shi VY. Medicare and medicaid spending trends for immunomodulators prescribed for dermatologic conditions. J Dermatolog Treat. 2022 Feb; 33(1):575-579. PMID: 32347760.
      View in: PubMed
    132. Shah M, Sachdeva M, Alavi A, Shi VY, Hsiao JL. Optimizing care for atopic dermatitis patients during the COVID-19 pandemic. J Am Acad Dermatol. 2020 08; 83(2):e165-e167. PMID: 32405123.
      View in: PubMed
    133. Sachdeva M, Price KN, Hsiao JL, Shi VY. Gender and rank salary trends among academic dermatologists. Int J Womens Dermatol. 2020 Sep; 6(4):324-326. PMID: 33015295.
      View in: PubMed
    134. Loh TY, Hsiao JL, Shi VY. COVID-19 and its effect on medical student education in dermatology. J Am Acad Dermatol. 2020 08; 83(2):e163-e164. PMID: 32413448.
      View in: PubMed
    135. Collier EK, Hsiao JL, Shi VY. Conducting clinical trials during the COVID-19 pandemic. J Dermatolog Treat. 2020 Jun; 31(4):330-332. PMID: 32343162.
      View in: PubMed
    136. Jaros J, Hendricks AJ, Shi VY, Lio PA. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis. Dermatitis. 2020 May-Jun; 31(3):169-177. PMID: 32355092.
      View in: PubMed
    137. Capozza K, Gadd H, Kelley K, Russell S, Shi V, Schwartz A. Insights From Caregivers on the Impact of Pediatric Atopic Dermatitis on Families: "I'm Tired, Overwhelmed, and Feel Like I'm Failing as a Mother". Dermatitis. 2020 May/Jun; 31(3):223-227. PMID: 32091463.
      View in: PubMed
    138. Fernandez JM, Collier EK, Foshee JP, Davis T, Hsiao JL, Shi VY. Invasive ductal carcinoma arising from an accessory nipple. JAAD Case Rep. 2020 Jun; 6(6):540-542. PMID: 32490120.
      View in: PubMed
    139. Collier EK, Price KN, Hsiao JL, Shi VY. Demystifying pharmaceutical patient assistance programs. J Dermatolog Treat. 2022 Feb; 33(1):336-341. PMID: 32308069.
      View in: PubMed
    140. Price KN, Thiede R, Shi VY, Curiel-Lewandrowski C. Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic. J Am Acad Dermatol. 2020 06; 82(6):e207-e209. PMID: 32277972.
      View in: PubMed
    141. Collier EK, Hsiao JL, Shi VY, Naik HB. Comprehensive approach to managing hidradenitis suppurativa patients. Int J Dermatol. 2020 Jun; 59(6):744-747. PMID: 32250448.
      View in: PubMed
    142. Price KN, Frew JW, Hsiao JL, Shi VY. COVID-19 and immunomodulator/immunosuppressant use in dermatology. J Am Acad Dermatol. 2020 05; 82(5):e173-e175. PMID: 32224277.
      View in: PubMed
    143. Price KN, Atluri S, Hsiao JL, Shi VY. Dermatology Foundation award trends. J Am Acad Dermatol. 2020 Nov; 83(5):1470-1473. PMID: 32199893.
      View in: PubMed
    144. Price KN, Thompson AM, Rizvi O, Hendricks AJ, Alavi A, Hsiao JL, Shi VY. Complementary and Alternative Medicine Use in Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2020 03 01; 156(3):345-348. PMID: 31995122.
      View in: PubMed
    145. Fernandez JM, Hurlbert MG, Shi VY. Response: Management challenges in prurigo nodularis. J Dermatolog Treat. 2022 02; 33(1):583-584. PMID: 32068455.
      View in: PubMed
    146. Collier E, Shi VY, Parvataneni RK, Lowes MA, Hsiao JL. Special considerations for women with hidradenitis suppurativa. Int J Womens Dermatol. 2020 Mar; 6(2):85-88. PMID: 32258337.
      View in: PubMed
    147. Saric-Bosanac S, Clark AK, Sivamani RK, Shi VY. The role of hypothalamus-pituitary-adrenal (HPA)-like axis in inflammatory pilosebaceous disorders. Dermatol Online J. 2020 Feb 15; 26(2). PMID: 32239884.
      View in: PubMed
    148. Loh TY, Hsiao JL, Shi VY. Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis. J Asthma Allergy. 2020; 13:109-114. PMID: 32104006.
      View in: PubMed
    149. Fernandez JM, Madsen S, Krase JM, Shi VY. Classification and mitigation of negative injection experiences with biologic medications. Dermatol Ther. 2020 03; 33(2):e13240. PMID: 32012405.
      View in: PubMed
    150. Collier E, Shi VY, Hsiao JL. Management of adolescents with hidradenitis suppurativa. J Dermatolog Treat. 2021 Dec; 32(8):1035-1038. PMID: 31933397.
      View in: PubMed
    151. McKenzie SA, Lev-Tov HA, Shi VY, Hsiao JL. Clinical Pearls for Managing Hidradenitis Suppurativa Patients of Low Socioeconomic Status. Dermatology. 2020; 236(5):439-444. PMID: 31927547.
      View in: PubMed
    152. Madsen SR, Hendricks AJ, Shi VY. Growing Patient Education in Dermatology: An Upside-Down Tree Analogy for Immunomodulatory Therapies J Drugs Dermatol. 2020 Jan 01; 19(1):28-29. PMID: 32227798.
      View in: PubMed
    153. Jaros J, Shi VY, Katta R. Diet and Chronic Urticaria: Dietary Modification as a Treatment Strategy. Dermatol Pract Concept. 2020; 10(1):e2020004. PMID: 31921491.
      View in: PubMed
    154. Price KN, Hsiao JL, Shi VY. Race and Ethnicity Gaps in Global Hidradenitis Suppurativa Clinical Trials. Dermatology. 2021; 237(1):97-102. PMID: 31865334.
      View in: PubMed
    155. Ludwig CM, Krase JM, Price KN, Lio PA, Shi VY. A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitis. J Dermatolog Treat. 2021 Aug; 32(5):503-506. PMID: 31619094.
      View in: PubMed
    156. Berman HS, Shi VY, Hsiao JL. Provider landscape for hidradenitis suppurativa patients. Int J Dermatol. 2020 May; 59(5):e164-e166. PMID: 31736054.
      View in: PubMed
    157. Mata E, Loh TY, Ludwig C, Price KN, Fernandez JM, Krase JM, Shi VY. Pharmacy costs of systemic and topical medications for atopic dermatitis. J Dermatolog Treat. 2021 Aug; 32(5):514-516. PMID: 31670992.
      View in: PubMed
    158. Hendricks AJ, Yosipovitch G, Shi VY. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review. J Dermatolog Treat. 2021 Feb; 32(1):19-28. PMID: 31693426.
      View in: PubMed
    159. Pourang A, Hendricks AJ, Shi VY. Managing dermatology patients who prefer "all natural" treatments. Clin Dermatol. 2020 May - Jun; 38(3):348-353. PMID: 32563348.
      View in: PubMed
    160. Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A Comparison of International Management Guidelines for Hidradenitis Suppurativa. Dermatology. 2021; 237(1):81-96. PMID: 31645040.
      View in: PubMed
    161. Yang EJ, Hendricks AJ, Beck KM, Shi VY. Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses. Dermatol Ther. 2019 11; 32(6):e13101. PMID: 31583790.
      View in: PubMed
    162. Patel N, McKenzie SA, Harview CL, Truong AK, Shi VY, Chen L, Grogan TR, Bennett RG, Hsiao JL. Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study. J Dermatolog Treat. 2021 Jun; 32(4):473-475. PMID: 31535587.
      View in: PubMed
    163. Hendricks AJ, Manivannan M, Shi VY. Clinical Pearls on Sleep Management in Atopic Dermatitis. Dermatitis. 2019 Sep/Oct; 30(5):287-293. PMID: 31524756.
      View in: PubMed
    164. Loh TY, Hendricks AJ, Hsiao JL, Shi VY. Undergarment and Fabric Selection in the Management of Hidradenitis Suppurativa. Dermatology. 2021; 237(1):119-124. PMID: 31466052.
      View in: PubMed
    165. Berman HS, Villa NM, Shi VY, Hsiao JL. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease. J Dermatolog Treat. 2021 Mar; 32(2):261-263. PMID: 31389737.
      View in: PubMed
    166. Hendricks AJ, Lio PA, Shi VY. Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis. Am J Clin Dermatol. 2019 Aug; 20(4):565-569. PMID: 30919315.
      View in: PubMed
    167. Hendricks AJ, Mills BW, Shi VY. Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends. J Dermatol Sci. 2019 Aug; 95(2):56-61. PMID: 31395434.
      View in: PubMed
    168. Heibel HD, Hendricks AJ, Foshee JP, Shi VY. Rosacea associated with dupilumab therapy. J Dermatolog Treat. 2021 Feb; 32(1):114-116. PMID: 31132923.
      View in: PubMed
    169. Hendricks AJ, Hirt PA, Sekhon S, Vaughn AR, Lev-Tov HA, Hsiao JL, Shi VY. Non-pharmacologic approaches for hidradenitis suppurativa - a systematic review. J Dermatolog Treat. 2021 Feb; 32(1):11-18. PMID: 31106609.
      View in: PubMed
    170. Cervantes J, Costello CM, Maarouf M, Kurtzman DJB, Shi VY. Computer-Based Video Instruction for Training Medical Students on Skin Biopsies. Dermatol Surg. 2019 06; 45(6):811-817. PMID: 30204735.
      View in: PubMed
    171. Hendricks AJ, Shi VY. Learning About Dupilumab-Associated Conjunctivitis. JAMA Dermatol. 2019 06 01; 155(6):754. PMID: 30994889.
      View in: PubMed
    172. Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY. Topical probiotics: the unknowns behind their rising popularity. Dermatol Online J. 2019 May 15; 25(5). PMID: 31220895.
      View in: PubMed
    173. Maarouf M, Hendricks AJ, Shi VY. Bathing Additives for Atopic Dermatitis - A Systematic Review. Dermatitis. 2019 May/Jun; 30(3):191-197. PMID: 31094942.
      View in: PubMed
    174. Maarouf M, Zullo SW, DeCapite T, Shi VY. Skin Cancer Epidemiology and Sun Protection Behaviors Among Native Americans J Drugs Dermatol. 2019 May 01; 18(5):420-423. PMID: 31141849.
      View in: PubMed
    175. Hendricks AJ, Lio PA, Shi VY. Dupilumab and Alopecia: Causative or Therapeutic? Dermatology. 2019; 235(4):306-307. PMID: 30999308.
      View in: PubMed
    176. Maarouf M, Kromenacker BW, Brucks ES, Hendricks AJ, Shi VY. 5-fluorouracil-induced erythema and transepidermal water loss associated with complete actinic keratosis resolution. Dermatol Ther. 2019 05; 32(3):e12890. PMID: 30942937.
      View in: PubMed
    177. Vaughn AR, Foolad N, Maarouf M, Tran KA, Shi VY. Micronutrients in Atopic Dermatitis: A Systematic Review. J Altern Complement Med. 2019 Jun; 25(6):567-577. PMID: 30912673.
      View in: PubMed
    178. Maarouf M, Kromenacker BW, Brucks ES, Hendricks A, Shi VY. Reducing unpleasant side effects of topical 5-Fluorouracil treatment for actinic keratosis: a randomized controlled trial. J Dermatolog Treat. 2020 Mar; 31(2):175-179. PMID: 30821548.
      View in: PubMed
    179. Kromenacker B, Maarouf M, Shi VY. Augmented Intelligence in Dermatology: Fantasy or Future? Dermatology. 2019; 235(3):250-252. PMID: 30889594.
      View in: PubMed
    180. Platto JF, Maarouf M, Hendricks A, Kurtzman DJ, Shi VY. Animated video consultation for reducing pre-operative anxiety in dermatologic surgery. Dermatol Online J. 2019 Mar 15; 25(3). PMID: 30982298.
      View in: PubMed
    181. Lee GR, Maarouf M, Hendricks AK, Lee DE, Shi VY. Current and emerging therapies for hand eczema. Dermatol Ther. 2019 05; 32(3):e12840. PMID: 30693618.
      View in: PubMed
    182. Maarouf M, Saberian C, Segal RJ, Shi VY. A New Era For Tattoos, with New Potential Complications. J Clin Aesthet Dermatol. 2019 Feb; 12(2):37-38. PMID: 30881582.
      View in: PubMed
    183. Costello C, Maarouf M, Shi V. Navigating Targeted Therapeutics in Dermatology: Biologics and Small Molecules J Drugs Dermatol. 2018 12 01; 17(12):1330-1332. PMID: 30586268.
      View in: PubMed
    184. Jaros J, Katta R, Shi VY. Dermatonutrigenomics: Past, Present, and Future. Dermatology. 2019; 235(2):164-166. PMID: 30485847.
      View in: PubMed
    185. Yang EJ, Beck KM, Bhutani T, Feldman SR, Shi VY. Pharmacy costs of systemic medications for hidradenitis suppurativa in the United States. J Dermatolog Treat. 2019 08; 30(5):519-521. PMID: 30256691.
      View in: PubMed
    186. Kempton DM, Maarouf M, Hendricks AJ, Shi VY. Erosive pustular dermatosis of the scalp associated with lamellar ichthyosis successfully treated with dehydrated human amnion/chorion membrane allograft. JAAD Case Rep. 2018 Nov; 4(10):1059-1061. PMID: 30510998.
      View in: PubMed
    187. Maarouf M, Curiel-Lewandrowski C, Daley S, Kuo P, Elquza E, Shi VY. Cutaneous erysipeloid metastasis of cholangiocarcinoma and evaluation by in?vivo reflectance confocal microscopy. JAAD Case Rep. 2018 Oct; 4(9):918-920. PMID: 30320195.
      View in: PubMed
    188. LePoidevin LM, Lee DE, Shi VY. A comparison of international management guidelines for atopic dermatitis. Pediatr Dermatol. 2019 Jan; 36(1):36-65. PMID: 30303557.
      View in: PubMed
    189. Zullo SW, Maarouf M, Shi VY. Acne disparities in Native Americans. J Am Acad Dermatol. 2021 Aug; 85(2):499-501. PMID: 30287325.
      View in: PubMed
    190. Maarouf M, Saberian C, Shi VY. Myths, Truths, and Clinical Relevance of Comedogenicity Product Labeling. JAMA Dermatol. 2018 10 01; 154(10):1131-1132. PMID: 29998304.
      View in: PubMed
    191. Maarouf M, Wickenheiser M, Krase JM, Wolter S, Shi VY. Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease. Pediatr Dermatol. 2018 Nov; 35(6):e391-e392. PMID: 30187970.
      View in: PubMed
    192. Maarouf M, Platto JF, Shi VY. The role of nutrition in inflammatory pilosebaceous disorders: Implication of the skin-gut axis. Australas J Dermatol. 2019 May; 60(2):e90-e98. PMID: 30175843.
      View in: PubMed
    193. Maarouf M, Kromenacker B, Capozza KL, Kempton D, Hendricks A, Tran K, Shi VY. Pain and Itch Are Dual Burdens in Atopic Dermatitis. Dermatitis. 2018 Sep/Oct; 29(5):278-281. PMID: 30179978.
      View in: PubMed
    194. Maarouf M, Saberian C, Lio PA, Shi VY. Head-and-neck dermatitis: Diagnostic difficulties and management pearls. Pediatr Dermatol. 2018 Nov; 35(6):748-753. PMID: 30152560.
      View in: PubMed
    195. Yang EJ, Beck KM, Maarouf M, Shi VY. Truths and myths in sunscreen labeling. J Cosmet Dermatol. 2018 Dec; 17(6):1288-1292. PMID: 30112840.
      View in: PubMed
    196. Maarouf M, Shi VY. Bleach for Atopic Dermatitis. Dermatitis. 2018 May/Jun; 29(3):120-126. PMID: 29762205.
      View in: PubMed
    197. Lee DE, Clark AK, Shi VY. Hidradenitis Suppurativa: Disease Burden and Etiology in Skin of Color. Dermatology. 2017; 233(6):456-461. PMID: 29495009.
      View in: PubMed
    198. Vaughn AR, Clark AK, Sivamani RK, Shi VY. Natural Oils for Skin-Barrier Repair: Ancient Compounds Now Backed by Modern Science. Am J Clin Dermatol. 2018 Feb; 19(1):103-117. PMID: 28707186.
      View in: PubMed
    199. Maarouf M, Alexander C, Shi VY. Nivolumab reactivation of hypertrophic lichen planus, a case report and review of published literature. Dermatol Online J. 2018 Jan 15; 24(1). PMID: 29469765.
      View in: PubMed
    200. Vaughn AR, Clark AK, Sivamani RK, Shi VY. Circadian rhythm in atopic dermatitis-Pathophysiology and implications for chronotherapy. Pediatr Dermatol. 2018 Jan; 35(1):152-157. PMID: 29231268.
      View in: PubMed
    201. Hendricks AJ, Vaughn AR, Clark AK, Yosipovitch G, Shi VY. Sweat mechanisms and dysfunctions in atopic dermatitis. J Dermatol Sci. 2018 Feb; 89(2):105-111. PMID: 29169766.
      View in: PubMed
    202. Maarouf M, Clark AK, Lee DE, Shi VY. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. J Dermatolog Treat. 2018 Aug; 29(5):441-449. PMID: 29098911.
      View in: PubMed
    203. Lee DE, Clark AK, Tran KA, Shi VY. New and emerging targeted systemic therapies: a new era for atopic dermatitis. J Dermatolog Treat. 2018 Jun; 29(4):364-374. PMID: 28853956.
      View in: PubMed
    204. Maarouf M, Sharon VR, Sivamani RK, Prakash N, Bipin TH, Davis T, Shi VY. Familial pseudoxanthoma elasticum associated with multiple comedones. Dermatol Online J. 2017 Sep 15; 23(9). PMID: 29469717.
      View in: PubMed
    205. Clark AK, Shi VY, Sivamani RK. Unique urticarial presentation of minocycline-induced lupus erythematosus. Dermatol Online J. 2017 Aug 15; 23(8). PMID: 29469742.
      View in: PubMed
    206. Vaughn AR, Sivamani RK, Lio PA, Shi VY. Paternal vs. Maternal Factors in Childhood Atopic Dermatitis. Dermatitis. 2017 Jul-Aug; 28(4):241-245. PMID: 28614111.
      View in: PubMed
    207. Vaughn AR, Tannhauser P, Sivamani RK, Shi VY. Mother Nature in Eczema: Maternal Factors Influencing Atopic Dermatitis. Pediatr Dermatol. 2017 May; 34(3):240-246. PMID: 28523877.
      View in: PubMed
    208. Kartan S, Shi VY, Clark AK, Chan LS. Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment. Am J Clin Dermatol. 2017 Feb; 18(1):105-126. PMID: 27878477.
      View in: PubMed
    209. Trusler AR, Clark AK, Sivamani RK, Shi VY. The Endocannabinoid System and Its Role in Eczematous Dermatoses. Dermatitis. 2017 Jan/Feb; 28(1):22-32. PMID: 28098721.
      View in: PubMed
    210. Petukhova TA, Foolad N, Prakash N, Shi VY, Sharon VR, O'Brecht L, Ali IA, Feldstein S, Halls J, Wang Q, Li CS, Sivamani RK. Objective volumetric grading of postacne scarring. J Am Acad Dermatol. 2016 Jul; 75(1):229-31. PMID: 27317527.
      View in: PubMed
    211. Ornelas J, Foolad N, Shi V, Burney W, Sivamani RK. Effect of Microneedle Pretreatment on Topical Anesthesia: A Randomized Clinical Trial. JAMA Dermatol. 2016 Apr; 152(4):476-7. PMID: 26762206.
      View in: PubMed
    212. Wilken R, Fung MA, Shi VY, Cheng MY, Patel F, Sultani H, Maverakis E. Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event. Dermatol Online J. 2016 Jan 15; 22(1). PMID: 26990469.
      View in: PubMed
    213. Tran KA, Cheng MY, Mitra A, Ogawa H, Shi VY, Olney LP, Kloxin AM, Maverakis E. MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy. Drug Des Devel Ther. 2016; 10:43-52. PMID: 26730180.
      View in: PubMed
    214. Foolad N, Prakash N, Shi VY, Kamangar F, Wang Q, Li CS, Sivamani RK. The use of facial modeling and analysis to objectively quantify facial redness. J Cosmet Dermatol. 2016 Mar; 15(1):43-8. PMID: 26534767.
      View in: PubMed
    215. Shi VY, Leo M, Hassoun L, Chahal DS, Maibach HI, Sivamani RK. Role of sebaceous glands in inflammatory dermatoses. J Am Acad Dermatol. 2015 Nov; 73(5):856-63. PMID: 26386632.
      View in: PubMed
    216. Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series. J Am Acad Dermatol. 2015 Oct; 73(4):645-54. PMID: 26259990.
      View in: PubMed
    217. Foolad N, Shi VY, Prakash N, Kamangar F, Sivamani RK. The association of the sebum excretion rate with melasma, erythematotelangiectatic rosacea, and rhytides. Dermatol Online J. 2015 Jun 16; 21(6). PMID: 26158356.
      View in: PubMed
    218. Bao L, Alexander JB, Shi VY, Mohan GC, Chan LS. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites. Immunology. 2014 Dec; 143(4):601-8. PMID: 24943510.
      View in: PubMed
    219. Shi VY, Joo JS, Sharon VR. Multiple labial melanotic macules occurring after topical application of calcineurin inhibitors. Dermatol Online J. 2014 Aug 17; 20(8). PMID: 25148283.
      View in: PubMed
    220. Shi VY, Lio PA. In-office diagnosis of cutaneous mycosis: a comparison of potassium hydroxide, Swartz-Lamkins, and chlorazol black E fungal stains. Cutis. 2013 Dec; 92(6):E8-10. PMID: 24416757.
      View in: PubMed
    221. Shi VY, Nanda S, Lee K, Armstrong AW, Lio PA. Improving patient education with an eczema action plan: a randomized controlled trial. JAMA Dermatol. 2013 Apr; 149(4):481-3. PMID: 23553035.
      View in: PubMed
    222. Bao L, Shi VY, Chan LS. IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of atopic dermatitis. Cytokine. 2013 Feb; 61(2):419-25. PMID: 23207180.
      View in: PubMed
    223. Shi VY, Bao L, Chan LS. Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4-transgenic mouse model. Microcirculation. 2012 Oct; 19(7):567-79. PMID: 22574929.
      View in: PubMed
    224. Shi VY, Tran K, Lio PA. A comparison of physicochemical properties of a selection of modern moisturizers: hydrophilic index and pH. J Drugs Dermatol. 2012 May; 11(5):633-6. PMID: 22527433.
      View in: PubMed
    225. Bao L, Shi VY, Chan LS. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis. Mol Immunol. 2012 Feb; 50(1-2):91-7. PMID: 22226123.
      View in: PubMed
    226. Shi VY, Lio PA. Lichenoid skin lesions. Arch Dis Child Educ Pract Ed. 2011 Dec; 96(6):209, 237. PMID: 22075177.
      View in: PubMed
    Shi's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (510) concept(s)
    _
    Co-Authors Expand Description
    See all (1) people
    _
    Similar People Expand Description
    See all (28) people
    _
    Same Department Expand Description
    Search Department